Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Twins, Conjoined | 4 | 2018 | 30 | 2.210 |
Why?
|
| Patient Care Planning | 3 | 2018 | 122 | 1.200 |
Why?
|
| Neonatal Nursing | 1 | 2018 | 6 | 0.580 |
Why?
|
| Mass Media | 1 | 2018 | 27 | 0.570 |
Why?
|
| Weight-Bearing | 1 | 2018 | 44 | 0.570 |
Why?
|
| Intensive Care, Neonatal | 1 | 2018 | 56 | 0.560 |
Why?
|
| Occupational Therapy | 1 | 2018 | 36 | 0.560 |
Why?
|
| Physical Therapy Modalities | 1 | 2018 | 52 | 0.560 |
Why?
|
| Diseases in Twins | 1 | 2018 | 89 | 0.550 |
Why?
|
| Pulmonary Fibrosis | 5 | 2019 | 111 | 0.510 |
Why?
|
| Delivery, Obstetric | 1 | 2018 | 255 | 0.480 |
Why?
|
| Social Support | 1 | 2018 | 369 | 0.470 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 334 | 0.460 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 3 | 2025 | 422 | 0.440 |
Why?
|
| Patient Discharge | 1 | 2018 | 495 | 0.430 |
Why?
|
| Patient Care Team | 1 | 2018 | 550 | 0.420 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 4 | 2016 | 134 | 0.410 |
Why?
|
| Health Personnel | 1 | 2018 | 533 | 0.400 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2012 | 58 | 0.380 |
Why?
|
| Macrophages, Alveolar | 3 | 2017 | 48 | 0.370 |
Why?
|
| Hypertension, Pulmonary | 4 | 2017 | 452 | 0.350 |
Why?
|
| Aging | 1 | 2018 | 1193 | 0.350 |
Why?
|
| Parents | 1 | 2018 | 1072 | 0.340 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 240 | 0.330 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 249 | 0.320 |
Why?
|
| Lung Volume Measurements | 2 | 2025 | 84 | 0.280 |
Why?
|
| Lung | 7 | 2025 | 1516 | 0.270 |
Why?
|
| Infant, Newborn | 5 | 2018 | 8347 | 0.270 |
Why?
|
| Infant, Premature | 1 | 2012 | 826 | 0.260 |
Why?
|
| Interleukin-6 | 4 | 2017 | 406 | 0.250 |
Why?
|
| Receptor, Adenosine A2B | 2 | 2017 | 10 | 0.250 |
Why?
|
| Adenosine | 2 | 2016 | 126 | 0.230 |
Why?
|
| Acute Lung Injury | 1 | 2024 | 64 | 0.210 |
Why?
|
| Fetal Growth Retardation | 1 | 2025 | 252 | 0.200 |
Why?
|
| Vitamin D | 1 | 2024 | 175 | 0.200 |
Why?
|
| Protein Isoforms | 2 | 2021 | 404 | 0.190 |
Why?
|
| Hyperoxia | 1 | 2024 | 134 | 0.190 |
Why?
|
| Balloon Occlusion | 1 | 2022 | 48 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 4504 | 0.180 |
Why?
|
| Animals, Newborn | 1 | 2024 | 1015 | 0.170 |
Why?
|
| Cytokines | 2 | 2024 | 1320 | 0.170 |
Why?
|
| Airway Obstruction | 1 | 2023 | 175 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 53 | 0.160 |
Why?
|
| Simulation Training | 1 | 2022 | 163 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2017 | 89 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 272 | 0.150 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2019 | 14 | 0.150 |
Why?
|
| Social Change | 1 | 2018 | 15 | 0.150 |
Why?
|
| Polyadenylation | 1 | 2019 | 46 | 0.140 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 441 | 0.140 |
Why?
|
| Patient Positioning | 1 | 2018 | 49 | 0.140 |
Why?
|
| Hymecromone | 1 | 2017 | 9 | 0.140 |
Why?
|
| Humans | 19 | 2025 | 126754 | 0.130 |
Why?
|
| Personality | 1 | 2018 | 112 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.130 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2016 | 15 | 0.130 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 101 | 0.120 |
Why?
|
| Equipment Design | 1 | 2018 | 575 | 0.120 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2015 | 6 | 0.120 |
Why?
|
| Gestational Age | 2 | 2025 | 1186 | 0.120 |
Why?
|
| Family | 1 | 2018 | 575 | 0.110 |
Why?
|
| Precision Medicine | 1 | 2018 | 345 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 361 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 835 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 374 | 0.110 |
Why?
|
| Transcriptome | 1 | 2021 | 1052 | 0.110 |
Why?
|
| Interleukin-17 | 1 | 2015 | 124 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2017 | 824 | 0.110 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2014 | 41 | 0.110 |
Why?
|
| Hypoxia | 1 | 2016 | 243 | 0.110 |
Why?
|
| Macrophages | 1 | 2017 | 640 | 0.100 |
Why?
|
| Bleomycin | 3 | 2019 | 110 | 0.100 |
Why?
|
| Urine | 1 | 2012 | 92 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1259 | 0.090 |
Why?
|
| Trachea | 2 | 2023 | 204 | 0.090 |
Why?
|
| Creatinine | 1 | 2012 | 381 | 0.080 |
Why?
|
| Mice | 8 | 2024 | 17596 | 0.080 |
Why?
|
| Female | 11 | 2025 | 68330 | 0.080 |
Why?
|
| Animals | 10 | 2024 | 33051 | 0.080 |
Why?
|
| Fetoscopy | 2 | 2023 | 456 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2025 | 992 | 0.070 |
Why?
|
| Quality of Life | 1 | 2018 | 2029 | 0.070 |
Why?
|
| Serine Endopeptidases | 2 | 2020 | 191 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4429 | 0.070 |
Why?
|
| Infant | 2 | 2023 | 12771 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2893 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 1753 | 0.060 |
Why?
|
| Pregnancy | 3 | 2025 | 7373 | 0.060 |
Why?
|
| Vascular Remodeling | 2 | 2017 | 46 | 0.060 |
Why?
|
| Myofibroblasts | 2 | 2019 | 60 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2019 | 4472 | 0.060 |
Why?
|
| Receptors, Mating Factor | 1 | 2006 | 2 | 0.060 |
Why?
|
| Pheromones | 1 | 2006 | 15 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2019 | 646 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2012 | 3314 | 0.060 |
Why?
|
| Fetal Weight | 1 | 2025 | 71 | 0.060 |
Why?
|
| Gene Expression | 2 | 2021 | 1482 | 0.060 |
Why?
|
| Pulmonary Edema | 1 | 2024 | 57 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2006 | 396 | 0.050 |
Why?
|
| Neurofibrillary Tangles | 1 | 2022 | 25 | 0.050 |
Why?
|
| Male | 7 | 2019 | 62543 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2025 | 665 | 0.050 |
Why?
|
| RNA Precursors | 1 | 2021 | 43 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2021 | 88 | 0.040 |
Why?
|
| Aniridia | 1 | 2001 | 11 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 1595 | 0.040 |
Why?
|
| MicroRNAs | 2 | 2019 | 872 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2023 | 346 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2021 | 296 | 0.040 |
Why?
|
| Aged | 4 | 2019 | 20344 | 0.040 |
Why?
|
| Fetus | 1 | 2022 | 578 | 0.040 |
Why?
|
| Age Distribution | 1 | 2020 | 422 | 0.040 |
Why?
|
| Exons | 1 | 2021 | 757 | 0.040 |
Why?
|
| Genome | 1 | 2021 | 464 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 416 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2019 | 154 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2019 | 129 | 0.040 |
Why?
|
| Risk Factors | 1 | 2012 | 10555 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2001 | 538 | 0.030 |
Why?
|
| Hyaluronan Synthases | 1 | 2017 | 12 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 223 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2016 | 3709 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 708 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 85 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 2975 | 0.030 |
Why?
|
| Actins | 1 | 2019 | 311 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 658 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2001 | 891 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 899 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 445 | 0.030 |
Why?
|
| Phenotype | 1 | 2006 | 4304 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 177 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2022 | 1025 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2021 | 2537 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2015 | 150 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2019 | 819 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2014 | 64 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 492 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2012 | 17005 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 99 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2014 | 106 | 0.030 |
Why?
|
| Adult | 3 | 2020 | 30410 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 442 | 0.030 |
Why?
|
| Middle Aged | 3 | 2019 | 27697 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 1877 | 0.020 |
Why?
|
| Collagen | 1 | 2014 | 290 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 2109 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1135 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2310 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 3038 | 0.020 |
Why?
|
| Genome, Fungal | 1 | 2006 | 31 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 2006 | 55 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 260 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 999 | 0.010 |
Why?
|
| PAX6 Transcription Factor | 1 | 2001 | 37 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2001 | 120 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 2001 | 75 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2001 | 121 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 135 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 125 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 622 | 0.010 |
Why?
|
| Child | 1 | 2020 | 25101 | 0.010 |
Why?
|
| Eye Proteins | 1 | 2001 | 229 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 412 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 946 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2883 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 1014 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 1185 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 1293 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 2541 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2001 | 761 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 3584 | 0.010 |
Why?
|
| Cell Line | 1 | 2001 | 2560 | 0.010 |
Why?
|